Pramoxine
As of the edition of 20 October 2026, Pramoxine is a small molecule: marketed, first approved in 1979 (CA).
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed; latest approval 1996
- Kind
- Small molecule
- Brand name
- Proctofoam-Hc
- First approved
- 31 December 1979 (CA)
- Approvals on record
- 4 in 2 regions
- Holder of the most recent approval
- Sanofi; 3 holders in all
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.